ACOR
Acorda Therapeutics, Inc.
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
16 hedge funds and large institutions have $2.3M invested in Acorda Therapeutics, Inc. in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
16
Holders Change
+1
Holders Change %
+6.67%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
3
Closed
2
Calls
$48K
Puts
–
Net Calls
+$48K
Net Calls Change
-$208K
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$161K |
2 |
2
Renaissance Technologies
New York
|
$690K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$2.01K |
4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$615 |
5 |
5
BlackRock
New York
|
$102K |
Top Sellers
1 |
1
Acadian Asset Management
Boston,
Massachusetts
|
$489K |
2 |
![]()
2
Group One Trading
Chicago,
Illinois
|
$0 |
3 |
3
Morgan Stanley
New York
|
$17.6K |
4 |
![]()
4
Fidelity Investments
Boston,
Massachusetts
|
$0 |